UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 30, 2015

 

 

The Advisory Board Company

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   000-33283   52-1468699

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

2445 M Street, NW

Washington, District of Columbia

  20037
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (202) 266-5600

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 1.01 Entry into a Material Definitive Agreement

Amendment to Credit Agreement

On October 30, 2015, The Advisory Board Company (the “Company”) entered into Amendment No. 2 (the “Amendment”) to its Credit Agreement, dated as of February 6, 2015 (as amended, the “Credit Agreement”), with the lenders party thereto, including JPMorgan Chase Bank, N.A., the Administrative Agent, in order to reduce the borrowing rates on the existing term loan and revolving credit facility and to increase the amount available for borrowing under the revolving credit facility, among other matters.

As reported in Item 1.01 of the Company’s current report on Form 8-K filed with the Securities and Exchange Commission on February 10, 2015, the lenders under the Credit Agreement on February 6, 2015 provided the Company with $675 million of senior secured credit facilities (the “Credit Facilities”). On that date, the Credit Facilities consisted of (a) a five-year senior secured term loan facility in the principal amount of $575 million (as amended from time to time, the “Term Facility”) and (b) a five-year senior secured revolving credit facility (as amended from time to time, the “Revolving Facility”) under which up to $100 million in principal amount of borrowings and other credit extensions may be outstanding at any time. Prior to the Amendment, the outstanding principal amount of the Term Facility was approximately $560.6 million, and no amounts were outstanding under the Revolving Facility. Pursuant to the Amendment, on October 30, 2015, the amount available for borrowing under the Revolving Facility was increased from $100 million to $200 million. On that date, the Company also borrowed $100 million under the Revolving Facility and used all of the proceeds from such borrowing to repay a portion of the outstanding principal amount of the Term Facility. Upon consummation of this prepayment transaction, $460.6 million in aggregate principal amount remained outstanding under the Term Facility.

The Company is the borrower under the Credit Facilities. The Company’s obligations under the Credit Facilities are guaranteed by the Company’s domestic subsidiaries, subject to certain exceptions, and the obligations of the Company and the subsidiary guarantors under the Credit Facilities are secured by a first-priority security interest in substantially all of the assets of the Company and such domestic subsidiaries.

Pursuant to the Amendment, commencing on October 30, 2015, amounts drawn under the Term Facility generally bear interest at an annual rate calculated, at the Company’s option, on the basis of either (a) an alternate base rate plus an initial margin of 1.25% or (b) the applicable London interbank offered rate (“LIBOR”) plus an initial margin of 2.25%, subject in each case to margin reductions based on the Company’s total leverage ratio. The interest rate on the alternate base rate loans will fluctuate as the base rate fluctuates, while the interest rate on the LIBOR loans will be adjusted at the end of each applicable interest period. Interest on alternate base rate loans will be payable quarterly in arrears, while interest on LIBOR loans will be payable at the end of each applicable interest period, except that, in the case of any interest period longer than three months, interest will be payable at the end of each three-month period.

Pursuant to the Amendment, commencing on October 30, 2015, amounts drawn under the Revolving Facility also generally bear interest at an annual rate calculated, at the Company’s option, on the basis of either (a) an alternate base rate plus an initial margin of 1.25% or (b) the applicable London interbank offered rate plus an initial margin of 2.25%, subject in each case to margin reductions based on the Company’s total leverage ratio.

The borrowing rates provided for in the Amendment as set forth above in each case represent a decrease of 50 basis points in the specified interest rate margins as compared to the previously applicable interest rate margins.

 

2


In connection with the Amendment, the Company paid each lender party to the Credit Agreement a consent fee equal to 0.02% of the amount loaned or committed for loan by such lender upon consummation of the transactions described above. The Company also paid an upfront fee equal to 0.30% of any increase in the amount loaned or committed for loan to any lender whose amount loaned or committed for loan increased as a result of the Amendment.

Certain of the lenders under the Credit Facilities and their affiliates previously have performed and in the future may perform financial advisory, commercial banking and investment banking services for the Company, for which they have received for past services, and are expected to receive for future services, customary fees and expense reimbursements.

A copy of the Amendment is filed as Exhibit 10.1 to this report. The foregoing description is not complete and is subject to and qualified in its entirety by reference to the text of the Amendment.

The information set forth under Item 2.03 of this report is incorporated by reference in this Item 1.01.

Item 2.02 Results of Operations and Financial Condition

On November 5, 2015, the Company issued a news release announcing its financial results for the fiscal quarter ended September 30, 2015. A copy of the Company’s news release is furnished as Exhibit 99.1 to this report.

 

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

The information set forth under Item 1.01 of this report is incorporated by reference in this Item 2.03.

On October 30, 2015, upon execution of the Amendment and consummation of the borrowing and prepayment transactions described in Item 1.01 of this report, the Company became obligated as the borrower, and certain of the Company’s domestic subsidiaries became obligated as guarantors, under $100 million in principal amount of senior secured indebtedness outstanding under the Revolving Facility. Subject to conditions of availability established under the Credit Agreement, the Company may become obligated as the borrower, and certain of the Company’s domestic subsidiaries may become obligated as guarantors, under up to an additional $100 million in principal amount of senior secured indebtedness outstanding under the Revolving Facility at any time.

On October 30, 2015, upon execution of the Amendment and consummation of the borrowing and prepayment transactions described in Item 1.01 of this report, the Company remained obligated as the borrower, and certain of the Company’s domestic subsidiaries remained obligated as guarantors, under $460.6 million in principal amount of senior secured indebtedness outstanding under the Term Facility.

The payment of all outstanding principal, interest and other amounts outstanding from time to time under the Credit Facilities may be declared immediately due and payable upon the occurrence of an event of default under the Credit Agreement. The Credit Facilities contain customary events of default, including an event of default upon a change of control of the Company. An event of default also will occur under the Credit Facilities, subject to customary grace periods for some covenants, if the Company or, in some cases, a subsidiary guarantor or other subsidiary fails to make payments when due, makes a material misrepresentation, fails to comply with affirmative or negative covenants, defaults on other material indebtedness, fails to discharge material judgments, becomes subject to certain claims under ERISA, fails to comply with certain material agreements, or, in the case of the Company or a material subsidiary,

 

3


becomes subject to specified events of bankruptcy, insolvency or reorganization or similar events. If an event of default occurs and is not cured within any applicable grace period or is not waived, the lenders under the Credit Facilities would have the right to accelerate repayment of the indebtedness and other obligations owing under the Credit Agreement and the guaranty executed by the subsidiary guarantors in favor of the lenders, and foreclose on certain pledged collateral, to the extent permitted under the loan documents and applicable law.

Item 8.01 Other Events

On November 5, 2015, the Company also announced that its Board of Directors has authorized an increase in its share repurchase program of up to an additional $100 million of the Company’s outstanding common stock, bringing the total amount authorized to be spent under the program to $550 million since its inception. Through September 30, 2015, the Company had repurchased approximately 17,435,688 shares of its common stock at a total cost of approximately $432 million. Repurchases will continue to be made from time to time in the open market or in private transactions. The repurchase program does not obligate the Company to repurchase any specific number of shares and may be modified or discontinued at any time.

Item 9.01 Financial Statements and Exhibits

 

(d) Exhibits

 

Exhibit

No.

  

Exhibit

10.1    Amendment No. 2, dated as of October 30, 2015, to that certain Credit Agreement, dated as of February 6, 2015, among The Advisory Board Company, the Lenders party thereto, JPMorgan Chase Bank, N.A., as Administrative Agent, and the other parties thereto.
99.1    News release of The Advisory Board Company dated November 5, 2015.

 

4


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

      The Advisory Board Company
Date: November 5, 2015      

/s/ Michael T. Kirshbaum

      Michael T. Kirshbaum
     

Chief Financial Officer

(Duly Authorized Officer)

 

5


EXHIBIT INDEX

 

Exhibit

No.

  

Description of Exhibit

10.1    Amendment No. 2, dated as of October 30, 2015, to that certain Credit Agreement, dated as of February 6, 2015, among The Advisory Board Company, the Lenders party thereto, JPMorgan Chase Bank, N.A., as Administrative Agent, and the other parties thereto.
99.1    News release of The Advisory Board Company dated November 5, 2015.


Exhibit 10.1

EXECUTION VERSION

AMENDMENT NO. 2, dated as of October 30, 2015 (this “Amendment No. 2”), to the Credit Agreement, dated as of February 6, 2015 and as amended by Amendment No. 1 thereto dated as of March 31, 2015 (the “Credit Agreement”), among THE ADVISORY BOARD COMPANY, a Delaware corporation (the “Borrower”), JPMORGAN CHASE BANK, N.A., as administrative agent (the “Administrative Agent”), each Lender from time to time party thereto and the other agents and arrangers party thereto. Capitalized terms used herein and not otherwise defined herein shall have the meanings ascribed to them in the Credit Agreement.

WHEREAS, Section 9.02(b) of the Credit Agreement provides that the Credit Agreement may be amended or waived to effect certain changes thereto with the written consent of the Administrative Agent and the Required Lenders and, with respect to certain changes, all Lenders or all Issuing Banks;

WHEREAS, the Borrower desires to amend, and the Borrower has requested that the Lenders, the Issuing Banks and the Administrative Agent agree to amend, the Credit Agreement on the terms set forth herein (collectively, the “Amendments”);

WHEREAS, in connection with the Amendments, the Borrower desires to increase the Aggregate Revolving Commitment to $200,000,000 and increase the aggregate amount of the Letter of Credit Sublimits to $25,000,000;

WHEREAS, substantially concurrently with the Amendments on the Amendment No. 2 Effective Date, the Borrower desires to (i) voluntarily prepay a portion of the Term Loans of certain Lenders in an aggregate amount equal to $100,000,000 and effect assignments of a portion of the Term Loans of certain of the Lenders to certain other Lenders such that on the Amendment No. 2 Effective Date after giving effect to such prepayments and assignments each Lender’s Term Loans shall be as set forth beside such Lender’s name on Annex A hereto and (ii) effect assignments of a portion of the new Revolving Commitments of certain of the Lenders to certain other Lenders such that on the Amendment No. 2 Effective Date after giving effect to such assignments each Lender’s Revolving Commitments shall be as set forth beside such Lender’s name on Annex B hereto, and the Borrower has requested that the Lenders consent to the voluntary prepayment of Term Loans set forth in clause (i) above and to the assignments of their Term Loans and Revolving Commitments, to the extent applicable, set forth in clauses (i) and (ii) (collectively, the “Prepayments Consent”);

WHEREAS, the Lenders signatory hereto, constituting all of the Lenders, each Issuing Bank and the Administrative Agent are willing to agree to the Amendments and the Prepayments Consent described herein, subject to the terms and conditions contained herein;

WHEREAS, the Lenders have agreed that, upon the Amendment No. 2 Effective Date, after giving effect to the prepayment and assignments of Term Loans described above, the Term Loans shall be as set forth on Annex A hereto and each Lender’s Term Loans, if any, shall be as set forth opposite such Lender’s name on Annex A hereto and after giving effect to the increase in the Aggregate Revolving Commitments and the assignments of new Revolving Commitments described above, the Revolving Commitments shall be as set forth on Annex B hereto and each Lender’s Revolving Commitment, if any, shall be as set forth opposite such Lender’s name on Annex B hereto;


WHEREAS, the Issuing Banks signatory hereto have agreed that, upon the Amendment No. 2 Effective Date, the Letter of Credit Sublimits shall be as set forth on Annex C hereto and each such Issuing Bank’s Letter of Credit Sublimit shall be as set forth opposite such Issuing Bank’s name on Annex C hereto; and

WHEREAS, J.P. Morgan Securities LLC and Merrill Lynch, Pierce, Fenner & Smith Incorporated are acting as joint lead arrangers in connection with this Amendment No. 2 (collectively, the “Amendment No. 2 Joint Lead Arrangers”);

NOW, THEREFORE, in consideration of the premises contained herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound hereby, agree as follows:

Section 1. Amendments. Subject to the satisfaction of the conditions set forth in Section 4 hereof, upon the Amendment No. 2 Effective Date, the Lenders party hereto consent to the following amendments to the Credit Agreement:

(a) The definition of “Aggregate Revolving Commitment” in Section 1.01 of the Credit Agreement is hereby amended by restating the second sentence thereof in its entirety as follows:

“As of the Amendment No. 2 Effective Date, the Aggregate Revolving Commitment is $200,000,000.”

(b) The definition of “Applicable Rate” in Section 1.01 of the Credit Agreement is hereby amended by restating the table contained therein in its entirety as follows:

 

     Total Leverage Ratio    Eurocurrency
Spread
    ABR Spread     Commitment
Fee Rate
 

Category 1:

   £ 1.25 to 1.00      1.50     0.50     0.20

Category 2:

   > 1.25 to 1.00 but £ 2.25 to 1.00      1.75     0.75     0.225

Category 3:

   > 2.25 to 1.00 but £ 3.25 to 1.00      2.00     1.00     0.25

Category 4:

   > 3.25 to 1.00      2.25     1.25     0.30

(c) The definition of “Joint Lead Arranger” in Section 1.01 of the Credit Agreement is hereby amended by inserting the following phrase at the end thereof: “and the Amendment No. 2 Joint Lead Arrangers.”

 

-2-


(d) Section 1.01 of the Credit Agreement is hereby amended by inserting the following defined terms in appropriate alphabetical order therein:

Amendment No. 2 Effective Date” means October 30, 2015, the date on which Amendment No. 2 to this Agreement became effective.

Amendment No. 2 Joint Lead Arrangers” means J.P. Morgan Securities LLC and Merrill Lynch, Pierce, Fenner & Smith Incorporated, as Joint Lead Arrangers with respect to Amendment No. 2 to this Agreement.

(e) Section 2.05(a) of the Credit Agreement is hereby amended by deleting the phrase “Subject to adjustment pursuant to paragraph (c) of this Section 2.05,” contained therein.

(f) Section 2.06(b) of the Credit Agreement is hereby amended by replacing the phrase “$10,000,000” contained therein with the phrase “$25,000,000”.

(g) Section 6.04(r) of the Credit Agreement is hereby amended by replacing the phrase “$75,000,000” contained therein with the phrase “$125,000,000”.

(h) Section 6.07(i) of the Credit Agreement is hereby amended by replacing the phrase “$75,000,000” contained therein with the phrase “$125,000,000”.

(i) Section 6.09(a)(v) of the Credit Agreement is hereby amended by replacing the phrase “$75,000,000” contained therein with the phrase “$125,000,000”.

(j) Schedule 2.01(a) of the Credit Agreement is hereby amended by amending and restating the table contained therein under the heading “Revolving Commitment” in its entirety as set forth on Annex B hereto. Each Lender party hereto agrees that, upon the Amendment No. 2 Effective Date, the Revolving Commitments shall be as set forth on Annex B hereto and each such Lender’s Revolving Commitment, if any, shall be as set forth opposite such Lender’s name on Annex B hereto. Any Revolving Loans outstanding under the Credit Agreement immediately prior to the Amendment No. 2 Effective Date shall be repaid with a substantially concurrent Borrowing of Revolving Loans immediately following the Amendment No. 2 Effective Date.

(k) Schedule 2.01(b) of the Credit Agreement is hereby amended and restated in its entirety as set forth on Annex C hereto. Each Issuing Bank agrees that, upon the Amendment No. 2 Effective Date, the Letter of Credit Sublimits shall be as set forth on Annex C hereto and each such Issuing Bank’s Letter of Credit Sublimit shall be as set forth opposite such Issuing Bank’s name on Annex C hereto.

Section 2. Prepayments Consent. Subject to the satisfaction of the conditions set forth in Section 4 hereof, upon the Amendment No. 2 Effective Date, the Lenders party hereto consent, without the delivery of any other prepayment notice, to the voluntary prepayment by the Borrower of the Term Loans of each applicable Lender in an aggregate amount equal to

 

-3-


$100,000,000, such that, after giving effect to such prepayments and the assignments referred to in the next succeeding sentence, the Term Loans of each Lender shall be as is set forth beside such Lender’s name on Annex A hereto, all on a non-pro rata basis. Subject to the satisfaction of the conditions set forth in Section 4 hereof, upon the Amendment No. 2 Effective Date, each Lender agrees that, without the delivery of any other assignment documentation, (i) each Lender with a greater amount of Term Loans set forth beside its name on Annex A hereto than it has outstanding immediately prior to the Amendment No. 2 Effective Date shall purchase by assignment an amount of Term Loans as directed by the Administrative Agent and (ii) each Lender with a lesser amount of Term Loans set forth beside its name on Annex A hereto than it has outstanding immediately prior to the Amendment No. 2 Effective Date shall sell by assignment an amount of Term Loans as directed by the Administrative Agent, in the case of each of clauses (i) and (ii) such that each Lender’s Term Loans on the Amendment No. 2 Effective Date shall be as set forth beside such Lender’s name on Annex A hereto. Upon the Amendment No. 2 Effective Date, each Lender agrees that, without the delivery of any other assignment documentation, each Lender with a lesser amount of Revolving Commitments set forth beside its name on Annex B hereto than it has outstanding immediately prior to the Amendment No. 2 Effective Date shall be deemed to have sold by assignment an amount of Revolving Commitments as directed by the Administrative Agent to one or more of the Lenders with a greater amount of Revolving Commitments set forth beside its name on Annex B hereto than it has outstanding immediately prior to the Amendment No. 2 Effective Date, such that after giving effect to the increase in the Aggregate Revolving Commitments and any deemed assignments, each Lender’s Revolving Commitments on the Amendment No. 2 Effective Date shall be as set forth beside such Lender’s name on Annex B hereto. Each Lender party hereto understands and agrees that such voluntary prepayments of Term Loans to occur on the Amendment No. 2 Effective Date shall not increase the Incremental Cap. Each of the Lenders party hereto hereby waives (x) any compensation pursuant to Section 2.16 of the Credit Agreement with respect to breakage costs or any other similar loss, cost or expense in connection with the prepayments of Eurocurrency Loans to occur on the Amendment No. 2 Effective Date, and (y) any right pursuant to Section 2.18(d) of the Credit Agreement to share ratably in the prepayments contemplated by this Section 2.

Section 3. Representations and Warranties. The Borrower represents and warrants to the Administrative Agent and each of the Lenders that:

(a) The execution and delivery of this Amendment No. 2 is within the Borrower’s organizational powers and has been duly authorized by all necessary organizational action on the part of the Borrower. This Amendment No. 2 has been duly executed and delivered by the Borrower and constitutes, a legal, valid and binding obligation of the Borrower, enforceable in accordance with its terms, subject to applicable bankruptcy, insolvency or similar laws affecting creditors’ rights generally, subject to general principles of equity and subject to implied covenants of good faith and fair dealing. This Amendment No. 2 will not (i) violate any Requirement of Law in any material respect, (ii) violate the articles of incorporation, bylaws or similar organizational documents of any Loan Party or (iii) violate or result in a default or require any consent or approval under any indenture, agreement or other instrument binding upon any Loan Party or its property, or give rise to a right thereunder to require any payment to be made by any Loan Party, except, in the case of this clause (iii), for violations, defaults or the creation of such rights that would not reasonably be expected to result in a Material Adverse Effect.

 

-4-


(b) Immediately prior to and immediately after giving effect to this Amendment No. 2, the representations and warranties set forth in Article III of the Credit Agreement and in any other Loan Document are true and correct in all material respects (except where such representations and warranties expressly relate to an earlier date, in which case such representations and warranties shall have been true and correct in all material respects as of such earlier date); provided that any representation and warranty that is qualified as to “materiality,” “material adverse effect” or similar language shall be true and correct in all respects (after giving effect to any such qualification therein).

(c) Immediately prior to and immediately after giving effect to this Amendment No. 2, no Default or Event of Default has occurred and is continuing.

Section 4. Conditions to Effectiveness. This Amendment No. 2 shall become effective as of the first date (the “Amendment No. 2 Effective Date”) on which the following conditions have been satisfied:

(a) the Administrative Agent (or its counsel) shall have received from all of the Lenders, all of the Issuing Banks and the Borrower either (i) a counterpart of this Amendment No. 2 signed on behalf of such Person or (ii) written evidence satisfactory to the Administrative Agent (which may include facsimile or .pdf transmission of a signed signature page of this Amendment No. 2) that such Person has signed a counterpart of this Amendment No. 2;

(b) the representations and warranties set forth in Section 3 hereof shall be true and correct as of the Amendment No. 2 Effective Date;

(c) the Borrower shall deliver or cause to be delivered a legal opinion with respect to this Amendment No. 2 of Hogan Lovells US LLP, as counsel to the Borrower, dated the Amendment No. 2 Effective Date;

(d) the Administrative Agent shall have received a certificate, dated the Amendment No. 2 Effective Date and signed by the President, a Vice President or a Financial Officer of the Borrower, confirming compliance with the condition precedent set forth in clause (b) of this Section 4;

(e) the Company shall have paid (i) for the account of each Lender party hereto, a consent fee equal to 0.02% of the aggregate principal amount of such Lender’s Term Loans and Revolving Commitments immediately prior to the Amendment No. 2 Effective Date and (ii) for the account of each Revolving Lender that has a greater amount of Revolving Commitments upon the Amendment No. 2 Effective Date than it did immediately prior to the Amendment No. 2 Effective Date, an upfront fee equal to the product of (a) 0.30% and (b) the Revolving Commitments of such Lender as of the Amendment No. 2 Effective Date, less (x) the Revolving Commitments of such Lender outstanding immediately prior to the Amendment No. 2 Effective Date, less (y) an amount (which shall not be less than zero) equal to (i) the aggregate

 

-5-


principal amount of Term Loans of such Lender outstanding immediately prior to the Amendment No. 2 Effective Date less (ii) the aggregate principal amount of Term Loans of such Lender outstanding on the Amendment No. 2 Effective Date;

(f) the Company shall have paid all reasonable out of pocket costs and expenses of the Administrative Agent and the Amendment No. 2 Joint Lead Arrangers in connection with the preparation, negotiation and execution of this Amendment No. 2 (including the reasonable fees and expenses of Cahill Gordon & Reindel LLP as counsel to the Administrative Agent and the Amendment No. 2 Joint Lead Arrangers); and

(g) substantially concurrently with the Amendment No. 2 Effective Date, the Borrower shall have prepaid such portion of the Term Loans of each Lender in an aggregate principal amount of $100,000,000, such that after giving effect to such prepayment and the assignments to occur on the Amendment No. 2 Effective Date, each Lender’s Term Loans shall be as set forth beside such Lender’s name on Annex A hereto, together with any accrued and unpaid interest and fees with respect thereto.

Section 5. Counterparts. This Amendment No. 2 may be executed in any number of counterparts and by the different parties hereto on separate counterparts, each of which when so executed and delivered shall be deemed to be an original, but all of which when taken together shall constitute a single instrument. Delivery of an executed counterpart of a signature page of this Amendment No. 2 by facsimile or other electronic transmission shall be effective as delivery of a manually executed counterpart hereof.

Section 6. Loan Document. This Amendment No. 2 shall constitute a Loan Document for all purposes under the Credit Agreement.

Section 7. Applicable Law. THIS AMENDMENT NO. 2 SHALL BE GOVERNED BY, AND CONSTRUED AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK.

Section 8. Headings. The headings of this Amendment No. 2 are for purposes of reference only and shall not limit or otherwise affect the meaning hereof.

Section 9. Effect of Amendment. Except as expressly set forth herein, this Amendment No. 2 (i) shall not by implication or otherwise limit, impair, constitute a waiver of or otherwise affect the rights and remedies of the Lenders, the Administrative Agent or the Issuing Banks, in each case under the Credit Agreement or any other Loan Document, and (ii) shall not alter, modify, amend or in any way affect any of the terms, conditions, obligations, covenants or agreements contained in the Credit Agreement or any other provision of either such agreement or any other Loan Document. Each and every term, condition, obligation, covenant and agreement contained in the Credit Agreement or any other Loan Document (for avoidance of doubt, in each case, as altered, modified or amended as expressly set forth herein) is hereby ratified and reaffirmed in all respects and shall continue in full force and effect.

[SIGNATURE PAGES FOLLOW]

 

-6-


IN WITNESS WHEREOF, the parties hereto have caused this Amendment No. 2 to be duly executed by their respective authorized officers as of the day and year first above written.

 

THE ADVISORY BOARD COMPANY, as Borrower
By:   /s/ Michael Kirshbaum
 

 

  Name:   Michael Kirshbaum
  Title:   Chief Financial Officer and Treasurer

[Amendment No. 2 Signature Page]


JPMORGAN CHASE BANK, N.A.,

as Administrative Agent

By:   /s/ James A. Knight
 

 

  Name:   James A. Knight
  Title:   Vice President

 

[Amendment No. 2 Signature Page]


JPMORGAN CHASE BANK, N.A.,

as Issuing Bank

By:   /s/ James A. Knight
 

 

  Name:   James A. Knight
  Title:   Vice President

 

[Amendment No. 2 Signature Page]


Bank of America, N.A.,

as Issuing Bank

By:   /s/ Monica Sevila
 

 

  Name:   Monica Sevila
  Title:   Senior Vice President

 

[Amendment No. 2 Signature Page]


MORGAN STANLEY BANK, N.A.,

as Issuing Bank

By:   /s/ Michael King
 

 

  Name:   Michael King
  Title:   Authorized Signatory

 

[Amendment No. 2 Signature Page]


The undersigned hereby executes this Amendment No. 2 as a Lender and (i) consents to the Amendments and the Prepayments Consent, (ii) agrees that, upon the Amendment No. 2 Effective Date, the Term Loans shall be as set forth on Annex A to Amendment No. 2 and such Lender’s Term Loans (after giving effect to the prepayments and assignments described in Amendment No. 2), if any, shall be as set forth opposite such Lender’s name on Annex A to Amendment No. 2 and (iii) agrees that, upon the Amendment No. 2 Effective Date, the Revolving Commitments shall be as set forth on Annex B to Amendment No. 2 and such Lender’s Revolving Commitment, if any, shall be as set forth opposite such Lender’s name on Annex B to Amendment No. 2:

 

JPMORGAN CHASE BANK, N.A.,

as a Lender

By:   /s/ James A. Knight
 

 

  Name:   James A. Knight
  Title:   Vice President

 

[Amendment No. 2 Signature Page]


The undersigned hereby executes this Amendment No. 2 as a Lender and (i) consents to the Amendments and the Prepayments Consent, (ii) agrees that, upon the Amendment No. 2 Effective Date, the Term Loans shall be as set forth on Annex A to Amendment No. 2 and such Lender’s Term Loans (after giving effect to the prepayments and assignments described in Amendment No. 2), if any, shall be as set forth opposite such Lender’s name on Annex A to Amendment No. 2 and (iii) agrees that, upon the Amendment No. 2 Effective Date, the Revolving Commitments shall be as set forth on Annex B to Amendment No. 2 and such Lender’s Revolving Commitment, if any, shall be as set forth opposite such Lender’s name on Annex B to Amendment No. 2:

 

Bank of America, N.A.,

as a Lender

By:   /s/ Monica Sevila
 

 

  Name:   Monica Sevila
  Title:   Senior Vice President

 

[Amendment No. 2 Signature Page]


The undersigned hereby executes this Amendment No. 2 as a Lender and (i) consents to the Amendments and the Prepayments Consent, (ii) agrees that, upon the Amendment No. 2 Effective Date, the Term Loans shall be as set forth on Annex A to Amendment No. 2 and such Lender’s Term Loans (after giving effect to the prepayments and assignments described in Amendment No. 2), if any, shall be as set forth opposite such Lender’s name on Annex A to Amendment No. 2 and (iii) agrees that, upon the Amendment No. 2 Effective Date, the Revolving Commitments shall be as set forth on Annex B to Amendment No. 2 and such Lender’s Revolving Commitment, if any, shall be as set forth opposite such Lender’s name on Annex B to Amendment No. 2:

 

     

SunTrust Bank,

as a Lender

      By:  

/s/ Dave Bennett

        Name:   Dave Bennett
        Title:   Director
  For any institution requiring a second signatory:     By:  

 

        Name:  
        Title:  

 

[Amendment No. 2 Signature Page]


The undersigned hereby executes this Amendment No. 2 as a Lender and (i) consents to the Amendments and the Prepayments Consent, (ii) agrees that, upon the Amendment No. 2 Effective Date, the Term Loans shall be as set forth on Annex A to Amendment No. 2 and such Lender’s Term Loans (after giving effect to the prepayments and assignments described in Amendment No. 2), if any, shall be as set forth opposite such Lender’s name on Annex A to Amendment No. 2 and (iii) agrees that, upon the Amendment No. 2 Effective Date, the Revolving Commitments shall be as set forth on Annex B to Amendment No. 2 and such Lender’s Revolving Commitment, if any, shall be as set forth opposite such Lender’s name on Annex B to Amendment No. 2:

 

MUFG Union Bank, N.A.,

as a Lender

By:  

/s/ Michael Gardner

  Name:   Michael Gardner
  Title:   Director

 

[Amendment No. 2 Signature Page]


The undersigned hereby executes this Amendment No. 2 as a Lender and (i) consents to the Amendments and the Prepayments Consent, (ii) agrees that, upon the Amendment No. 2 Effective Date, the Term Loans shall be as set forth on Annex A to Amendment No. 2 and such Lender’s Term Loans (after giving effect to the prepayments and assignments described in Amendment No. 2), if any, shall be as set forth opposite such Lender’s name on Annex A to Amendment No. 2 and (iii) agrees that, upon the Amendment No. 2 Effective Date, the Revolving Commitments shall be as set forth on Annex B to Amendment No. 2 and such Lender’s Revolving Commitment, if any, shall be as set forth opposite such Lender’s name on Annex B to Amendment No. 2:

 

Wells Fargo Bank, N.A.,

as a Lender

By:  

/s/ Frank S. Kaulback, III

  Name:   Frank S. Kaulback, III
  Title:   Senior Vice President

 

[Amendment No. 2 Signature Page]


The undersigned hereby executes this Amendment No. 2 as a Lender and (i) consents to the Amendments and the Prepayments Consent, (ii) agrees that, upon the Amendment No. 2 Effective Date, the Term Loans shall be as set forth on Annex A to Amendment No. 2 and such Lender’s Term Loans (after giving effect to the prepayments and assignments described in Amendment No. 2), if any, shall be as set forth opposite such Lender’s name on Annex A to Amendment No. 2 and (iii) agrees that, upon the Amendment No. 2 Effective Date, the Revolving Commitments shall be as set forth on Annex B to Amendment No. 2 and such Lender’s Revolving Commitment, if any, shall be as set forth opposite such Lender’s name on Annex B to Amendment No. 2:

 

PNC BANK, NATIONAL ASSOCIATION,

as a Lender

By:  

/s/ Steven Day

  Name:   Steven Day
  Title:   Assistant Vice President

 

[Amendment No. 2 Signature Page]


The undersigned hereby executes this Amendment No. 2 as a Lender and (i) consents to the Amendments and the Prepayments Consent, (ii) agrees that, upon the Amendment No. 2 Effective Date, the Term Loans shall be as set forth on Annex A to Amendment No. 2 and such Lender’s Term Loans (after giving effect to the prepayments and assignments described in Amendment No. 2), if any, shall be as set forth opposite such Lender’s name on Annex A to Amendment No. 2 and (iii) agrees that, upon the Amendment No. 2 Effective Date, the Revolving Commitments shall be as set forth on Annex B to Amendment No. 2 and such Lender’s Revolving Commitment, if any, shall be as set forth opposite such Lender’s name on Annex B to Amendment No. 2:

 

REGIONS BANK,

as a Lender

By:  

/s/ Bruce Rudolph

  Name:   Bruce Rudolph
  Title:   Vice President

 

[Amendment No. 2 Signature Page]


The undersigned hereby executes this Amendment No. 2 as a Lender and (i) consents to the Amendments and the Prepayments Consent, (ii) agrees that, upon the Amendment No. 2 Effective Date, the Term Loans shall be as set forth on Annex A to Amendment No. 2 and such Lender’s Term Loans (after giving effect to the prepayments and assignments described in Amendment No. 2), if any, shall be as set forth opposite such Lender’s name on Annex A to Amendment No. 2 and (iii) agrees that, upon the Amendment No. 2 Effective Date, the Revolving Commitments shall be as set forth on Annex B to Amendment No. 2 and such Lender’s Revolving Commitment, if any, shall be as set forth opposite such Lender’s name on Annex B to Amendment No. 2:

 

Citizens Bank, N.A,

as a Lender

By:  

/s/ William McClassy

  Name:   William McClassy
  Title:   Sr. Vice President

 

[Amendment No. 2 Signature Page]


The undersigned hereby executes this Amendment No. 2 as a Lender and (i) consents to the Amendments and the Prepayments Consent, (ii) agrees that, upon the Amendment No. 2 Effective Date, the Term Loans shall be as set forth on Annex A to Amendment No. 2 and such Lender’s Term Loans (after giving effect to the prepayments and assignments described in Amendment No. 2), if any, shall be as set forth opposite such Lender’s name on Annex A to Amendment No. 2 and (iii) agrees that, upon the Amendment No. 2 Effective Date, the Revolving Commitments shall be as set forth on Annex B to Amendment No. 2 and such Lender’s Revolving Commitment, if any, shall be as set forth opposite such Lender’s name on Annex B to Amendment No. 2:

 

HSBC Bank USA, N.A.,

as a Lender

By:  

/s/ John P Treadwell Jr.

  Name:   John P Treadwell Jr.
  Title:   Vice President

 

RESTRICTED - [Amendment No. 2 Signature Page]


The undersigned hereby executes this Amendment No. 2 as a Lender and (i) consents to the Amendments and the Prepayments Consent, (ii) agrees that, upon the Amendment No. 2 Effective Date, the Term Loans shall be as set forth on Annex A to Amendment No. 2 and such Lender’s Term Loans (after giving effect to the prepayments and assignments described in Amendment No. 2), if any, shall be as set forth opposite such Lender’s name on Annex A to Amendment No. 2 and (iii) agrees that, upon the Amendment No. 2 Effective Date, the Revolving Commitments shall be as set forth on Annex B to Amendment No. 2 and such Lender’s Revolving Commitment, if any, shall be as set forth opposite such Lender’s name on Annex B to Amendment No. 2:

 

     

HEALTHCARE FINANCIAL SOLUTIONS, LLC,

as a Lender

      By:  

/s/ Hanes Whiteley

        Name:   Hanes Whiteley
        Title:   Duly Authorized Signatory
  For any institution requiring a second signatory:     By:  

 

        Name:  
        Title:  

 

[Amendment No. 2 Signature Page]


The undersigned hereby executes this Amendment No. 2 as a Lender and (i) consents to the Amendments and the Prepayments/Terminations Consent, (ii) agrees that, upon the Amendment No. 2 Effective Date, the Term Loans shall be as set forth on Annex A to Amendment No. 2 and such Lender’s Term Loans (after giving effect to the prepayments and assignments described in Amendment No. 2), if any, shall be as set forth opposite such Lender’s name on Annex A to Amendment No. 2 and (iii) agrees that, upon the Amendment No. 2 Effective Date, the Revolving Commitments shall be as set forth on Annex B to Amendment No. 2 and such Lender’s Revolving Commitment, if any, shall be as set forth opposite such Lender’s name on Annex B to Amendment No. 2:

 

Capital One, N.A.,

As a Lender

By:  

/s/ Katherine A. Marcotte

  Name:   Katherine A. Marcotte
  Title:   Senior Vice President

 

[Amendment No. 2 Signature Page]


The undersigned hereby executes this Amendment No. 2 as a Lender and (i) consents to the Amendments and the Prepayments Consent, (ii) agrees that, upon the Amendment No. 2 Effective Date, the Term Loans shall be as set forth on Annex A to Amendment No. 2 and such Lender’s Term Loans (after giving effect to the prepayments and assignments described in Amendment No. 2), if any, shall be as set forth opposite such Lender’s name on Annex A to Amendment No. 2 and (iii) agrees that, upon the Amendment No. 2 Effective Date, the Revolving Commitments shall be as set forth on Annex B to Amendment No. 2 and such Lender’s Revolving Commitment, if any, shall be as set forth opposite such Lender’s name on Annex B to Amendment No. 2:

 

Barclays Bank PLC,

as a Lender

By:  

/s/ Mathew Cybul

  Name:   Mathew Cybul
  Title:   Assistant Vice President

 

[Amendment No. 2 Signature Page]


The undersigned hereby executes this Amendment No. 2 as a Lender and (i) consents to the Amendments and the Prepayments Consent, (ii) agrees that, upon the Amendment No. 2 Effective Date, the Term Loans shall be as set forth on Annex A to Amendment No. 2 and such Lender’s Term Loans (after giving effect to the prepayments and assignments described in Amendment No. 2), if any, shall be as set forth opposite such Lender’s name on Annex A to Amendment No. 2 and (iii) agrees that, upon the Amendment No. 2 Effective Date, the Revolving Commitments shall be as set forth on Annex B to Amendment No. 2 and such Lender’s Revolving Commitment, if any, shall be as set forth opposite such Lender’s name on Annex B to Amendment No. 2:

 

     

TD Bank, N.A.,

as a Lender

      By:  

/s/ Mark Worthy

        Name:   Mark Worthy
        Title:   Vice President
  For any institution requiring a second signatory:     By:  

 

        Name:  
        Title:  

 

[Amendment No. 2 Signature Page]


The undersigned hereby executes this Amendment No. 2 as a Lender and (i) consents to the Amendments and the Prepayments Consent, (ii) agrees that, upon the Amendment No. 2 Effective Date, the Term Loans shall be as set forth on Annex A to Amendment No. 2 and such Lender’s Term Loans (after giving effect to the prepayments and assignments described in Amendment No. 2), if any, shall be as set forth opposite such Lender’s name on Annex A to Amendment No. 2 and (iii) agrees that, upon the Amendment No. 2 Effective Date, the Revolving Commitments shall be as set forth on Annex B to Amendment No. 2 and such Lender’s Revolving Commitment, if any, shall be as set forth opposite such Lender’s name on Annex B to Amendment No. 2:

 

RAYMOND JAMES BANK, N.A.,

as a Lender

By:  

/s/ Alexander L. Rody

  Name:   Alexander L. Rody
  Title:   Senior Vice President

 

[Amendment No. 2 Signature Page]


The undersigned hereby executes this Amendment No. 2 as a Lender and (i) consents to the Amendments and the Prepayments/Terminations Consent, (ii) agrees that, upon the Amendment No. 2 Effective Date, the Term Loans shall be as set forth on Annex A to Amendment No. 2 and such Lender’s Term Loans (after giving effect to the prepayments and assignments described in Amendment No. 2), if any, shall be as set forth opposite such Lender’s name on Annex A to Amendment No. 2 and (iii) agrees that, upon the Amendment No. 2 Effective Date, the Revolving Commitments shall be as set forth on Annex B to Amendment No. 2 and such Lender’s Revolving Commitment, if any, shall be as set forth opposite such Lender’s name on Annex B to Amendment No. 2

 

Morgan Stanley Senior Funding, Inc.,

as a Lender

By:  

/s/ Michael King

  Name:   Michael King
  Title:   Vice President

 

[Amendment No. 2 Signature Page]


The undersigned hereby executes this Amendment No. 2 as a Lender and (i) consents to the Amendments and the Prepayments/Terminations Consent, (ii) agrees that, upon the Amendment No. 2 Effective Date, the Term Loans shall be as set forth on Annex A to Amendment No. 2 and such Lender’s Term Loans (after giving effect to the prepayments and assignments described in Amendment No. 2), if any, shall be as set forth opposite such Lender’s name on Annex A to Amendment No. 2 and (iii) agrees that, upon the Amendment No. 2 Effective Date, the Revolving Commitments shall be as set forth on Annex B to Amendment No. 2 and such Lender’s Revolving Commitment, if any, shall be as set forth opposite such Lender’s name on Annex B to Amendment No. 2:

 

Morgan Stanley Bank, N.A.,

as a Lender

By:  

/s/ Michael King

  Name:   Michael King
  Title:   Authorized Signatory

 

[Amendment No. 2 Signature Page]


The undersigned hereby executes this Amendment No. 2 as a Lender and (i) consents to the Amendments and the Prepayments Consent, (ii) agrees that, upon the Amendment No. 2 Effective Date, the Term Loans shall be as set forth on Annex A to Amendment No. 2 and such Lender’s Term Loans (after giving effect to the prepayments and assignments described in Amendment No. 2), if any, shall be as set forth opposite such Lender’s name on Annex A to Amendment No. 2 and (iii) agrees that, upon the Amendment No. 2 Effective Date, the Revolving Commitments shall be as set forth on Annex B to Amendment No. 2 and such Lender’s Revolving Commitment, if any, shall be as set forth opposite such Lender’s name on Annex B to Amendment No. 2:

 

      United Bank as a Lender
      By:  

/s/ Tom Wolcott

        Tom Wolcott
        SVP Shared National Credit
  For any institution requiring a second signatory:     By:  

 

        Name:  
        Title:  

 

[Amendment No. 2 Signature Page]


The undersigned hereby executes this Amendment No. 2 as a Lender and (i) consents to the Amendments and the Prepayments Consent, (ii) agrees that, upon the Amendment No. 2 Effective Date, the Term Loans shall be as set forth on Annex A to Amendment No. 2 and such Lender’s Term Loans (after giving effect to the prepayments and assignments described in Amendment No. 2), if any, shall be as set forth opposite such Lender’s name on Annex A to Amendment No. 2 and (iii) agrees that, upon the Amendment No. 2 Effective Date, the Revolving Commitments shall be as set forth on Annex B to Amendment No. 2 and such Lender’s Revolving Commitment, if any, shall be as set forth opposite such Lender’s name on Annex B to Amendment No. 2:

 

     

GENERAL ELECTRIC CAPITAL CORPORATION,

as a Lender

      By:  

/s/ Hanes Whiteley

        Name:   Hanes Whiteley
        Title:   Duly Authorized Signatory
  For any institution requiring a second signatory:     By:  

 

        Name:  
        Title:  

 

[Amendment No. 2 Signature Page]


Annex A

Term Loans

 

Lender

   Term Loans  

JPMorgan Chase Bank, N.A.

   $ 51,180,555.64   

Bank of America, N.A.

   $ 51,180,555.56   

SunTrust Bank

   $ 40,944,444.44   

MUFG Union Bank, N.A.

   $ 34,120,370.36   

Wells Fargo Bank, N.A.

   $ 34,120,370.36   

PNC Bank, National Association

   $ 34,120,370.36   

Regions Bank

   $ 34,120,370.36   

Citizens Bank, N.A.

   $ 34,120,370.36   

HSBC Bank USA, N.A.

   $ 23,884,259.25   

Healthcare Financial Solutions, LLC

   $ 23,884,259.25   

Capital One, N.A.

   $ 23,884,259.25   

Barclays Bank PLC

   $ 23,884,259.25   

TD Bank, N.A.

   $ 21,065,619.98   

Raymond James Bank, N.A.

   $ 20,027,173.91   

Morgan Stanley Senior Funding, Inc.

   $ 6,082,326.89   

United Bank

   $ 4,005,434.78   
  

 

 

 

Total

   $ 460,625,000.00   
  

 

 

 


Annex B

Revolving Commitment

 

Revolving Lender

   Revolving Commitment  

JPMorgan Chase Bank, N.A.

   $ 22,222,222.22   

Bank of America, N.A.

   $ 22,222,222.21   

MUFG Union Bank, N.A.

   $ 20,032,206.12   

SunTrust Bank

   $ 17,777,777.78   

Wells Fargo Bank, N.A.

   $ 14,814,814.82   

PNC Bank, National Association

   $ 14,814,814.82   

Regions Bank

   $ 14,814,814.82   

Citizens Bank, N.A.

   $ 14,814,814.82   

HSBC Bank USA, N.A.

   $ 10,370,370.37   

Healthcare Financial Solutions, LLC

   $ 10,370,370.37   

Capital One, N.A.

   $ 10,370,370.37   

Barclays Bank PLC

   $ 10,370,370.37   

Morgan Stanley Bank, N.A.

   $ 8,727,858.29   

TD Bank, N.A.

   $ 8,276,972.62   

General Electric Capital Corporation

   $ 0.00   
  

 

 

 

Total

   $ 200,000,000.00   
  

 

 

 


Annex C

Schedule 2.01(b) – LETTER OF CREDIT SUBLIMITS

 

L/C Issuer

   Letter of Credit Sublimit  

JPMorgan Chase Bank, N.A.

   $ 12,500,000   

Bank of America, N.A.

   $ 7,500,000   

Morgan Stanley Bank, N.A.

   $ 5,000,000   


Exhibit 99.1

 

LOGO

 

Contact:    Michael Kirshbaum    The Advisory Board Company
   Chief Financial Officer    2445 M Street, N.W.
   c/o Bianca Alonso    Washington, D.C. 20037
   202.266.5803    www.advisory.com
   IR@advisory.com   

THE ADVISORY BOARD COMPANY REPORTS RESULTS FOR

QUARTER ENDED SEPTEMBER 30, 2015

Company Reports Revenue Growth of 39%, Contract Value Growth of 35%, and Announces $100M Increase to Share Repurchase Program

WASHINGTON, D.C. — (November 5, 2015) — The Advisory Board Company (NASDAQ: ABCO), a global technology, research, and services company providing the leading cloud-based comprehensive performance platform for the health care and higher education industries, today announced financial results for the quarter ended September 30, 2015.

Highlights from the third quarter of 2015 are as follows (all comparisons, unless otherwise noted, are to the quarter ended September 30, 2014):

 

    Revenue of $200.2 million, an increase of 39%

 

    Contract value of $760.3 million, an increase of 35%

 

    Adjusted EBITDA of $43.4 million, an increase of 71%

 

    Non-GAAP earnings per diluted share of $0.33

Robert Musslewhite, Chairman and Chief Executive Officer of The Advisory Board Company, commented, “We are pleased with our performance for the quarter and the value we are delivering to our members as they face ongoing change and complexity in their markets. Our results reflect the powerful attributes of our business very clearly, with the combination of rapid top line growth along with even faster EBITDA growth, expanding margins, and solid cash generation. A keen focus on execution across the quarter allowed us to produce excellent operating outcomes, and we are well on pace to end the year with momentum and deliver key financial metrics within the guidance range we provided back in February.”

Mr. Musslewhite continued, “Across these final two months of the year we are heavily focused on continuing to drive outstanding member impact and flawless execution in order to finish the important December quarter strong and to put ourselves in the best possible position for 2016 and beyond.”

Third Quarter Financial Review

Revenue increased 39% to $200.2 million in the quarter ended September 30, 2015, up from $144.2 million for the quarter ended September 30, 2014. Contract value increased 35% to $760.3 million as of September 30, 2015, up from $561.6 million as of September 30, 2014.


Net income attributable to common stockholders was $1.9 million, or $0.04 per diluted share, for the quarter ended September 30, 2015, compared to net income attributable to common stockholders of $6.5 million, or $0.18 per diluted share, for the quarter ended September 30, 2014. Adjusted net income was $14.1 million for the quarter ended September 30, 2015, compared to $15.9 million for the quarter ended September 30, 2014. Non-GAAP earnings per diluted share was $0.33 for the quarter ended September 30, 2015, compared to $0.43 for the quarter ended September 30, 2014.

Adjusted EBITDA increased 71% to $43.4 million for the quarter ended September 30, 2015, up from $25.4 million for the quarter ended September 30, 2014.

Adjusted revenue, adjusted net income, non-GAAP earnings per diluted share, and adjusted EBITDA are non-GAAP financial measures.

Year-to-Date Financial Review

Revenue increased 33% to $564.7 million for the nine month period ended September 30, 2015, up from $424.0 million for the nine month period ended September 30, 2014. Adjusted revenue, which adjusts for the effect on revenue of fair value adjustments to acquired deferred revenue, increased 36% to $577.2 million for the nine month period ended September 30, 2015, up from $424.0 million for the nine month period ended September 30, 2014. Net loss attributable to common stockholders was $13.1 million, or $0.31 per diluted share, for the nine month period ended September 30, 2015, compared to net income attributable to common stockholders of $11.6 million, or $0.31 per diluted share, for the nine month period ended September 30, 2014. Adjusted EBITDA was $129.9 million for the nine month period ended September 30, 2015, up from $75.4 million for the nine month period ended September 30, 2014. Adjusted net income was $44.3 million for the nine month period ended September 30, 2015, up from $39.5 million for the nine month period ended September 30, 2014. Non-GAAP earnings per diluted share was $1.04 for the nine month period ended September 30, 2015, compared to $1.07 for the nine month period ended September 30, 2014.

Share Repurchase Authorization Increased by $100 Million

During the three months ended September 30, 2015, the Company repurchased approximately 678,000 shares of its common stock at a total cost of $33.0 million. Since 2004, the Company has repurchased approximately 17.4 million shares of its common stock at a total cost of $431.8 million.

The Company also announced that its Board of Directors authorized an increase in its share repurchase program of up to an additional $100 million of the Company’s common stock, bringing the total amount authorized to be spent under the program to $550 million. Repurchases will continue to be made from time to time in the open market or in private transactions. The repurchase program does not obligate the Company to repurchase any specific number of shares and may be modified or discontinued at any time. The Company will fund its share repurchases with cash on hand and cash generated from operations.

Outlook for Calendar Year 2015

The Company is reaffirming its annual financial guidance. For calendar year 2015, the Company continues to expect:

 

    Adjusted revenue to be in a range of approximately $780 million to $790 million

 

    Adjusted EBITDA to be in a range of approximately $170 million to $175 million

 

    Non-GAAP earnings per diluted share to be in a range of approximately $1.30 to $1.37

 

    Adjusted effective tax rate to be in a range of approximately 45% to 47%

Conference Call Information

As previously announced, the Company will hold a conference call to discuss its third quarter performance this evening, November 5, 2015, at 5:30 p.m. Eastern Time. The conference call will be available via live webcast on the Company’s website at www.advisory.com/IR. To participate by telephone, the dial-in number is 888.336.7150.


Participants are advised to dial in at least five minutes prior to the call to register. The webcast will be archived for seven days from 8:00 p.m. Eastern Time on Thursday, November 5, 2015, until 11:00 p.m. Eastern Time on Thursday, November 12, 2015. The Company invites all interested parties to attend the conference call, including the lenders under the Company’s senior secured credit facilities.

A supplemental presentation of information complementary to the information presented in this release and that will be discussed on the conference call will be made available on the Company’s website at www.advisory.com/IR prior to the conference call and will be archived for the same duration as the webcast.

About the Advisory Board Company

The Advisory Board Company is the leading provider of insight-driven technology, research, and services for organizations in transforming industries. Through its innovative membership model, the Company collaborates with more than 230,000 leaders at 5,200 member organizations to elevate performance and solve their most pressing problems. The Company provides strategic guidance, actionable insights, cloud-based software solutions, and comprehensive implementation and management services. For more information, visit www.advisory.com.

Non-GAAP Financial Measures

This news release presents information about the Company’s adjusted revenue, adjusted net income, non-GAAP earnings per diluted share, adjusted EBITDA, adjusted effective tax rate, and adjusted weighted average common shares outstanding-diluted, which are non-GAAP financial measures provided as a complement to the results provided in accordance with accounting principles generally accepted in the United States of America (“GAAP”). A reconciliation of each of the foregoing historical non-GAAP financial measures to the most directly comparable historical GAAP financial measures is provided in the accompanying tables found at the end of this release for each of the fiscal periods indicated.

Caution Regarding Forward-Looking Statements

Statements in this news release that relate to future results and events are forward-looking statements and are based on the Company’s expectations as of the date of this news release. In some cases, you can identify these statements by such forward-looking words as “anticipate,” “believe,” “estimate,” “expect,” “guidance,” “intend,” “may,” “outlook,” “plan,” “potential,” “should,” “will,” “would,” or similar words or expressions. Forward-looking statements in this news release include the Company’s expectations regarding its performance and results for fiscal 2015 with respect to adjusted revenue, adjusted EBITDA, non-GAAP earnings per diluted share, and adjusted effective tax rate.

Actual results and events in future periods may differ materially from those expressed or implied by these forward-looking statements because of a number of risks, uncertainties, and other factors, including those relating to: factors that adversely affect the financial condition of the health care and higher education industries; federal and state law and regulations governing the health care and higher education industries and our members’ and our respective compliance with those applicable laws and regulations; the Company’s ability to sustain high renewal rates on its memberships; maintenance of the Company’s reputation and expansion of its name recognition; the Company’s ability to offer new and valuable products and services; effects of competition; the Company’s ability to maintain a highly-skilled workforce; unsuccessful design or implementation of software or delivery of consulting and management services; delays in generating revenue; effects of federal and state privacy and security laws and cyber attacks and other data security breaches; compliance with federal regulations governing electronic transactions; service disruptions and operational or security failures; ability to collect and maintain member and third party data and to obtain proper permissions and waivers for use and disclosure of information received from members or on their behalf; liability for failure to provide accurate information or for deficient submissions to third-party payors; compliance with federal and state laws governing healthcare fraud and abuse or reimbursement; maintenance of third-party providers and strategic alliances and entry into new alliances; licensing and integration of third-party technologies and data; protection of the Company’s intellectual property; claims of infringement, misappropriation, or violation of proprietary rights of third parties; limitations associated with use of open source technology; changes to estimates and assumptions used to prepare the Company’s consolidated financial statements; any significant increase in bad debt in excess of recorded estimates; failure to realize the anticipated


benefits of the Royall acquisition; diversion of management’s attention from operations by activities focused on the integration of Royall’s business; business and financial risk associated with the pursuit of acquisition opportunities; delays in the delivery by Evolent Health to the Company of its financial statements; any significant impairment of the Company’s goodwill; the Company’s ability to realize a return on its strategic investments; the level of the Company’s debt service obligations and restrictions on its operations under debt covenants; potential imposition of sales and use taxes on sales of the Company’s services; the Company’s ability to realize fully its deferred tax assets; inherent limitations in, and the potential impact of any failure to maintain, effective internal control over financial reporting; effects of issuance of additional capital stock; and provisions in the Company’s charter and bylaws that could discourage takeover attempts.

This list of risks, uncertainties, and other factors is not complete. The Company discusses some of these matters more fully, as well as certain risk factors that could affect the Company’s business, financial condition, results of operations, and prospects, in its filings with the Securities and Exchange Commission, including the Company’s annual report on form 10-KT for the transition period ended December 31, 2014 and its quarterly reports on Form 10-Q and current reports on Form 8-K. These filings are available for review through the Securities and Exchange Commission’s website at www.sec.gov. Any or all forward-looking statements the Company makes may turn out to be wrong, and can be affected by inaccurate assumptions the Company might make or by known or unknown risks, uncertainties, and other factors, including those identified in this news release. Accordingly, you should not place undue reliance on the forward-looking statements made in this news release, which speak only as of its date. The Company does not undertake to update any of its forward-looking statements, whether as a result of circumstances or events that arise after the date they are made, new information, or otherwise.

###

Reconciliation of Non-GAAP Financial Measures

This news release presents information about the Company’s adjusted revenue, adjusted EBITDA, adjusted net income, non-GAAP earnings per diluted share, adjusted effective tax rate, and adjusted weighted average common shares outstanding-diluted, which are non-GAAP financial measures provided as a complement to the results provided in accordance with GAAP.

A reconciliation of each of the foregoing historical non-GAAP financial measures to the most directly comparable historical GAAP financial measures is provided below for each of the fiscal periods indicated. It is not practicable to provide a reconciliation of forecasted adjusted revenue, adjusted EBITDA, adjusted net income, non-GAAP earnings per diluted share, or adjusted effective tax rate to the most directly comparable GAAP financial measures because certain items required for the forecast of such GAAP financial measures, including fair value adjustments to acquisition-related earn-out liabilities, equity in income (loss) of unconsolidated entity, and gains and losses on investment in common stock warrants, cannot reasonably be estimated or predicted at this time.

 

     Three Months Ended
September 30,
     Nine Months Ended
September 30,
 
     2015      2014      2015      2014  

Revenue

   $ 200,238       $ 144,220       $ 564,694       $ 424,041   

Effect on revenue of fair value adjustments to acquisition-related deferred revenue

     —           —           12,499         —     
  

 

 

    

 

 

    

 

 

    

 

 

 

Adjusted revenue

   $ 200,238       $ 144,220       $ 577,193       $ 424,041   
  

 

 

    

 

 

    

 

 

    

 

 

 
     Three Months Ended
September 30,
     Nine Months Ended
September 30,
 
     2015      2014      2015      2014  

Net income (loss) attributable to common stockholders

   $ 1,856       $ 6,490       $ (13,117    $ 11,600   

Effect on revenue of fair value adjustments to acquisition-related deferred revenue

     —           —           12,499         —     

Equity in loss of unconsolidated entities

     3,289         1,197         1,668         6,078   

Accretion of noncontrolling interest to redemption value

     —           (150      —           6,890   

Provision for income taxes

     7,156         710         12,066         11,540   

Interest expense

     5,450         —           16,333         —     

Other expense (income), net

     1,150         851         2,280         (591

Loss on financing activities

     —           —           17,398         —     

Depreciation and amortization

     18,494         9,679         55,067         27,225   

Acquisition and similar transaction charges

     —           —           6,610         268   

Fair value adjustments to acquisition-related earn-out liabilities

     (1,057      (400      (2,140      (4,600

Vacation accrual adjustment

     —           850         (850      850   

Stock-based compensation expense

     7,094         6,175         22,130         16,139   
  

 

 

    

 

 

    

 

 

    

 

 

 

Adjusted EBITDA

   $ 43,432       $ 25,402       $ 129,944       $ 75,399   
  

 

 

    

 

 

    

 

 

    

 

 

 


     Three Months Ended
September 30,
     Nine Months Ended
September 30,
 
     2015      2014      2015      2014  

Net income (loss) attributable to common stockholders

   $ 1,856       $ 6,490       $ (13,117    $ 11,600   

Effect of adjusted tax rate on net (loss) income

     1,510         —           11,640         —     

Effect on revenue of fair value adjustments to acquisition-related deferred revenue, net of adjusted tax rate

     —           —           7,047         —     

Equity in loss of unconsolidated entities

     3,289         1,197         1,668         6,078   

Accretion of noncontrolling interest to redemption value

     —           (150      —           6,890   

Amortization of acquisition-related intangibles, net of adjusted tax rate

     4,188         2,261         12,970         5,144   

Loss on financing activities, net of adjusted tax rate

     —           —           9,725         —     

Acquisition and similar transaction charges, net of adjusted tax rate

     —           —           3,704         162   

Fair value adjustments to acquisition-related earn-out liabilities, net of adjusted tax rate

     (572      (366      (1,191      (2,949

(Gain) loss on investment in common stock warrants, net of adjusted tax rate

     —           —           (40      108   

Vacation accrual adjustment, net of adjusted tax rate

     —           777         (475      777   

Stock-based compensation expense, net of adjusted tax rate

     3,838         5,643         12,320         11,714   
  

 

 

    

 

 

    

 

 

    

 

 

 

Adjusted net income

   $ 14,109       $ 15,852       $ 44,251       $ 39,524   
  

 

 

    

 

 

    

 

 

    

 

 

 
     Three Months Ended
September 30,
     Nine Months Ended
September 30,
 
     2015      2014      2015      2014  

Net income (loss) attributable to common shareholders per share - Diluted

   $ 0.04       $ 0.18       $ (0.31    $ 0.31   

Effect of adjusted tax rate on net (loss) income

     0.04         —           0.27         —     

Effect on revenue of fair value adjustments to acquisition-related deferred revenue, net of adjusted tax rate

     —           —           0.16         —     

Equity in loss of unconsolidated entities

     0.08         0.03         0.04         0.16   

Accretion of noncontrolling interest to redemption value

     —           —           —           0.19   

Amortization of acquisition-related intangibles, net of adjusted tax rate

     0.10         0.06         0.31         0.15   

Loss on financing activities, net of adjusted tax rate

     —           —           0.23         —     

Acquisition and similar transaction charges, net of adjusted tax rate

     —           —           0.09         —     

Fair value adjustments to acquisition-related earn-out liabilities, net of adjusted tax rate

     (0.02      (0.01      (0.03      (0.08

Gain (loss) on investment in common stock warrants, net of adjusted tax rate

     —           —           —           —     

Vacation accrual adjustment, net of adjusted tax rate

     —           0.02         (0.01      0.02   

Stock-based compensation expense, net of adjusted tax rate

     0.09         0.15         0.29         0.32   
  

 

 

    

 

 

    

 

 

    

 

 

 

Non-GAAP earnings per diluted share

   $ 0.33       $ 0.43       $ 1.04       $ 1.07   
  

 

 

    

 

 

    

 

 

    

 

 

 


     Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
     2015     2014     2015     2014  

Effective tax rate

     58.2     8.6     1,955.6     32.0

Effect on tax rate of Washington, D.C. tax law change, including write-off of Washington, D.C. income tax credits

     —          —          (1,773.6 %)      —     

Effect on tax rate of loss on financing activities

     (9.0 %)      —          (17.9 %)      —     

Effect on tax rate of unconsolidated equity method investment related FIN 48 liability

     —          —          —          —     

Effect on tax rate of Royall acquisition costs and other acquisition-related tax items

     (3.3 %)      —          (119.7 %)      —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted effective tax rate

     45.9     8.6     44.4     32.0
  

 

 

   

 

 

   

 

 

   

 

 

 
     Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
     2015     2014     2015     2014  

Weighted average common shares outstanding – Diluted

     42,788        36,703        41,900        36,983   

Diluted shares outstanding (1)

     —          —          525        —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted weighted average common shares outstanding – Diluted

     42,788        36,703        42,425        36,983   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

(1) For non-GAAP purposes the Company has net income, therefore has included diluted shares in its calculation of non-GAAP EPS.


THE ADVISORY BOARD COMPANY

UNAUDITED CONSOLIDATED STATEMENTS OF INCOME

AND OTHER OPERATING STATISTICS

(In thousands, except per share data)

 

     Three Months Ended
September 30,
    Selected
Growth
    Nine Months Ended
September 30,
    Selected
Growth
 
     2015     2014     Rates     2015     2014     Rates  

Statements of Income

            

Revenue (1)

   $ 200,238      $ 144,220        38.8   $ 564,694      $ 424,041        33.2
  

 

 

   

 

 

     

 

 

   

 

 

   

Cost of services, excluding depreciation and amortization (2) (3)

     101,373        74,078          288,901        215,491     

Member relations and marketing (2)

     30,792        26,792          90,893        79,780     

General and administrative (2) (4) (5)

     30,678        24,573          93,205        66,028     

Depreciation and amortization (6)

     18,494        9,679          55,067        27,225     
  

 

 

   

 

 

     

 

 

   

 

 

   

Operating income

     18,901        9,098          36,628        35,517     

Other (expense) income

            

Interest expense

     (5,450     —            (16,333     —       

Other (expense) income, net

     (1,150     (851       (2,280     591     

Loss on financing activities

     —          —            (17,398     —       
  

 

 

   

 

 

     

 

 

   

 

 

   

Total other (expense) income, net

     (6,600     (851       (36,011     591     
  

 

 

   

 

 

     

 

 

   

 

 

   

Income before provision for income taxes and equity in loss of unconsolidated entities

     12,301        8,247          617        36,108     

Provision for income taxes

     (7,156     (710       (12,066     (11,540  

Equity in loss of unconsolidated entities

     (3,289     (1,197       (1,668     (6,078  
  

 

 

   

 

 

     

 

 

   

 

 

   

Net income (loss) before allocation to noncontrolling interest

     1,856        6,340          (13,117     18,490     

Net loss and accretion to redemption value of noncontrolling interest

     —          150          —          (6,890  
  

 

 

   

 

 

     

 

 

   

 

 

   

Net income (loss) attributable to common stockholders

   $ 1,856      $ 6,490        $ (13,117   $ 11,600     
  

 

 

   

 

 

     

 

 

   

 

 

   

Net (loss) income attributable to common stockholders per share

            

Basic

   $ 0.04      $ 0.18        $ (0.31   $ 0.32     

Diluted

   $ 0.04      $ 0.18        $ (0.31   $ 0.31     

Weighted average common shares outstanding

            

Basic

     42,320        36,191          41,900        36,270     

Diluted

     42,788        36,703          41,900        36,983     

Contract Value (at end of period)

   $ 760,301      $ 561,645        35.4      

Percentages of Revenue

            

Cost of services, excluding depreciation and amortization (2) (3)

     50.6     51.4       51.2     50.8  

Member relations and marketing (2)

     15.4     18.6       16.1     18.8  

General and administrative (2) (4) (5)

     15.3     17.0       16.5     15.6  

Depreciation and amortization (6)

     9.2     6.7       9.8     6.4  

Operating income

     9.4     6.3       6.5     8.4  

Net income (loss) attributable to common stockholders

     0.9     4.5       -2.3     2.7  

 

(1)    Amounts include effect on revenue of fair value adjustments to acquisition-related deferred revenue, as follows:

       

 

Revenue

     —          —            (12,499     —       

(2)    Amounts include stock-based compensation, as follows:

       

 

Cost of services

     2,423        1,916          6,881        5,387     

Member relations and marketing

     1,306        1,141          3,907        3,065     

General and administrative

     3,365        3,118          11,342        7,687     

(3)    Amounts include fair value adjustments of acquisition-related earn-out liabilities, as follows:

       

 

Cost of services

     (1,057     (400       (2,140     (4,600  

(4)    Amounts include acquisition and transaction related costs, as follows:

       

 

General and administrative

     —          —            6,610        268     

(5)    Amounts include reversal of vacation accrual charge related to change in fiscal year as follows:

       

 

General and administrative

     —          850          (850     850     

(6)    Amounts include amortization of acquisition-related intangibles, as follows:

       

 

Depreciation and amortization

     7,740        2,473          23,320        7,201     


THE ADVISORY BOARD COMPANY

CONSOLIDATED BALANCE SHEETS

(In thousands)

 

     September 30,
2015
    December 31,
2014
 
     (unaudited)        

ASSETS

    

Current assets:

    

Cash and cash equivalents

   $ 56,075      $ 72,936   

Marketable securities, current

     —          14,714   

Membership fees receivable, net

     604,075        539,061   

Prepaid expenses and other current assets

     25,388        23,254   

Deferred income taxes, current

     16,159        14,695   
  

 

 

   

 

 

 

Total current assets

     701,697        664,660   

Property and equipment, net

     182,934        135,107   

Intangible assets, net

     285,440        38,973   

Deferred incentive compensation and other charges

     80,787        86,045   

Goodwill

     842,859        186,895   

Investments in unconsolidated entities

     3,077        9,316   

Other non-current assets

     5,698        5,370   
  

 

 

   

 

 

 

Total assets

   $ 2,102,492      $ 1,126,366   
  

 

 

   

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

    

Current liabilities:

    

Deferred revenue, current

   $ 586,360      $ 501,785   

Accounts payable and accrued liabilities

     76,295        80,284   

Accrued incentive compensation

     27,851        32,073   

Debt, current

     27,885        —     
  

 

 

   

 

 

 

Total current liabilities

     718,391        614,142   

Deferred revenue, net of current portion

     157,911        167,014   

Deferred income taxes, net of current portion

     119,707        9,855   

Debt, net of current portion

     529,422        —     

Other long-term liabilities

     12,101        15,304   
  

 

 

   

 

 

 

Total liabilities

     1,537,532        806,315   
  

 

 

   

 

 

 

Stockholders’ equity:

    

Common stock

     419        361   

Additional paid-in capital

     735,024        442,528   

Accumulated deficit

     (169,030     (122,920

Accumulated other comprehensive income

     (1,453     82   
  

 

 

   

 

 

 

Total stockholders’ equity

     564,960        320,051   
  

 

 

   

 

 

 

Total liabilities and stockholders’ equity

   $ 2,102,492      $ 1,126,366   
  

 

 

   

 

 

 


THE ADVISORY BOARD COMPANY

UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

 

     Nine Months Ended
September 30,
 
     2015     2014  

Cash flows from operating activities:

    

Net (loss) income before allocation to noncontrolling interest

   $ (13,117   $ 18,490   

Adjustments to reconcile net (loss) income before allocation to noncontrolling interest to net cash provided by operating activities:

    

Depreciation and amortization

     55,067        27,225   

Loss on financing activities

     17,398        —     

Amortization of debt issuance costs

     983        —     

Deferred income taxes

     9,912        11,018   

Excess tax benefits from stock-based awards

     (2,804     (5,011

Stock-based compensation expense

     22,130        16,139   

Amortization of marketable securities premiums

     —          1,664   

(Gain) loss on investment in common stock warrants

     (70     180   

Equity in loss of unconsolidated entities

     1,668        6,078   

Changes in operating assets and liabilities (net of the effect of acquisition):

    

Membership fees receivable

     (35,774     (10,876

Prepaid expenses and other current assets

     7,978        (5,746

Deferred incentive compensation and other charges

     2,977        7,248   

Other non-current assets

     (258     —     

Deferred revenue

     57,172        (19,634

Accounts payable and accrued liabilities

     (5,595     (4,264

Acquisition-related earn-out payments

     (2,198     (3,073

Accrued incentive compensation

     (4,222     (8,659

Other long-term liabilities

     (3,203     (8,088
  

 

 

   

 

 

 

Net cash provided by operating activities

     108,044        22,691   
  

 

 

   

 

 

 

Cash flows from investing activities:

    

Purchases of property and equipment

     (39,985     (35,000

Capitalized external use software development costs

     (2,965     (3,871

Cash paid for acquisitions, net of cash acquired

     (746,693     (25,830

Cash paid for investment in unconsolidated entity

     (3,006     —     

Redemptions of marketable securities

     14,714        85,959   

Purchases of marketable securities

     —          (32,657
  

 

 

   

 

 

 

Net cash used in investing activities

     (777,935     (11,399
  

 

 

   

 

 

 

Cash flows from financing activities:

    

Proceeds from debt, net

     1,280,292        —     

Pay down of debt

     (739,377     —     

Debt issuance costs

     (2,568     —     

Proceeds from issuance of common stock, net of selling costs

     148,786        —     

Proceeds from issuance of common stock from exercise of stock options

     3,262        6,927   

Withholding of shares to satisfy minimum employee tax withholding

     (6,058     (7,735

Proceeds from issuance of stock under employee stock purchase plan

     389        445   

Acquisition-related earn-out payments

     (1,500     —     

Excess tax benefits from stock-based awards

     2,804        5,011   

Purchases of treasury stock

     (33,000     (41,772
  

 

 

   

 

 

 

Net cash provided by (used in) financing activities

     653,030        (37,124
  

 

 

   

 

 

 

Net decrease in cash and cash equivalents

     (16,861     (25,832

Cash and cash equivalents, beginning of period

     72,936        52,717   
  

 

 

   

 

 

 

Cash and cash equivalents, end of period

   $ 56,075      $ 26,885   
  

 

 

   

 

 

 
The Advisory Board Company (MM) (NASDAQ:ABCO)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more The Advisory Board Company (MM) Charts.
The Advisory Board Company (MM) (NASDAQ:ABCO)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more The Advisory Board Company (MM) Charts.